Intuitive Surgical Beheer

Beheer criteriumcontroles 2/4

De CEO Intuitive Surgical is Gary Guthart, benoemd in Jan2010, heeft een ambtstermijn van 14.83 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 12.45M, bestaande uit 7.7% salaris en 92.3% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.35% van de aandelen van het bedrijf, ter waarde € 640.50M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 2.8 jaar en 6.4 jaar.

Belangrijke informatie

Gary Guthart

Algemeen directeur

US$12.4m

Totale compensatie

Percentage CEO-salaris	7.7%
Dienstverband CEO	14.8yrs
Eigendom CEO	0.4%
Management gemiddelde ambtstermijn	2.8yrs
Gemiddelde ambtstermijn bestuur	6.4yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Gary Guthart's beloning veranderd ten opzichte van Intuitive Surgical's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Sep 30 2024	n/a	n/a	US$2b
Jun 30 2024	n/a	n/a	US$2b
Mar 31 2024	n/a	n/a	US$2b
Dec 31 2023	US$12m	US$955k	US$2b
Sep 30 2023	n/a	n/a	US$2b
Jun 30 2023	n/a	n/a	US$1b
Mar 31 2023	n/a	n/a	US$1b
Dec 31 2022	US$10m	US$873k	US$1b
Sep 30 2022	n/a	n/a	US$1b
Jun 30 2022	n/a	n/a	US$1b
Mar 31 2022	n/a	n/a	US$2b
Dec 31 2021	US$8m	US$846k	US$2b
Sep 30 2021	n/a	n/a	US$2b
Jun 30 2021	n/a	n/a	US$2b
Mar 31 2021	n/a	n/a	US$1b
Dec 31 2020	US$6m	US$821k	US$1b
Sep 30 2020	n/a	n/a	US$1b
Jun 30 2020	n/a	n/a	US$1b
Mar 31 2020	n/a	n/a	US$1b
Dec 31 2019	US$6m	US$790k	US$1b
Sep 30 2019	n/a	n/a	US$1b
Jun 30 2019	n/a	n/a	US$1b
Mar 31 2019	n/a	n/a	US$1b
Dec 31 2018	US$6m	US$767k	US$1b
Sep 30 2018	n/a	n/a	US$804m
Jun 30 2018	n/a	n/a	US$810m
Mar 31 2018	n/a	n/a	US$778m
Dec 31 2017	US$5m	US$744k	US$671m

Compensatie versus markt: De totale vergoeding ($USD 12.45M ) Gary } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de German markt ($USD 4.86M ).

Compensatie versus inkomsten: De vergoeding van Gary is het afgelopen jaar met meer dan 20% gestegen.

CEO

Gary Guthart (58 yo)

14.8yrs

Tenure

US$12,449,381

Compensatie

Dr. Gary S. Guthart, Ph.D. has been Chief Executive Officer of Intuitive Surgical, Inc. since January 1, 2010 and was its President since July 12, 2007. Dr. Guthart served as the Chief Operating Officer at...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Gary Guthart	CEO & Director	14.8yrs	US$12.45m	0.35% € 640.5m
David Rosa	President & Director	1.5yrs	US$12.56m	0.059% € 107.7m
Jamie Samath	Senior VP & CFO	2.8yrs	US$5.03m	0.0025% € 4.5m
Henry Charlton	Senior VP & Chief Commercial and Marketing Officer	1.5yrs	US$5.10m	0.00084% € 1.5m
Robert DeSantis	Executive VP and Chief Strategy & Corporate Operations Officer	9yrs	US$4.84m	0.0015% € 2.8m
Fredrik Widman	VP, Principal Accounting Officer & Corporate Controller	4.8yrs	geen gegevens	0.000030% € 54.5k
Brian King	VP, Treasurer & Head of Investor Relations	no data	geen gegevens	geen gegevens
Gary Loeb	Senior VP	2.2yrs	geen gegevens	0.00085% € 1.5m
Christopher Carlson	Executive Vice President of Research	less than a year	geen gegevens	geen gegevens
Patricia Wadors	Chief Human Resources Officer	less than a year	geen gegevens	geen gegevens
Myriam J. McAdams	Executive VP & Chief Medical Officer	10.8yrs	US$4.48m	0.000080% € 145.4k
Brian Miller	Executive VP & Chief Digital Officer	9.4yrs	geen gegevens	0.0020% € 3.6m

2.8yrs

Gemiddelde duur

57yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van IUI1 wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.8 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Gary Guthart	CEO & Director	15.6yrs	US$12.45m	0.35% € 640.5m
David Rosa	President & Director	less than a year	US$12.56m	0.059% € 107.7m
Amal Johnson	Independent Director	14.6yrs	US$388.12k	0.0034% € 6.3m
Joseph Beery	Independent Director	4.6yrs	US$379.79k	0.00067% € 1.2m
Craig Barratt	Independent Chairman	13.6yrs	US$498.74k	0.0073% € 13.3m
Lewis Chew	Director	less than a year	geen gegevens	0.000010% € 18.2k
Jami K. Nachtsheim	Independent Director	7.6yrs	US$383.12k	0.0016% € 2.9m
Keith Leonard	Independent Director	8.8yrs	US$379.79k	0.00045% € 817.9k
Amy Ladd	Independent Director	5.3yrs	US$376.79k	0.00023% € 418.0k
Mark Rubash	Independent Director	17.1yrs	US$392.46k	0.0045% € 8.2m
Monica Reed	Independent Director	3.6yrs	US$376.79k	0.00045% € 817.9k
Sreelakshmi Kolli	Independent Director	1.1yrs	US$142.84k	0.000070% € 127.2k

6.4yrs

Gemiddelde duur

61.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van IUI1 wordt beschouwd als ervaren (gemiddelde ambtstermijn 6.4 jaar).

Intuitive Surgical Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

Intuitive Appoints David J. Rosa as Board of Directors

Intuitive Elects Lewis Chew as Board of Directors

Intuitive Surgical, Inc., Annual General Meeting, Apr 25, 2024

Intuitive Surgical, Inc. Appoints Sreelakshmi Kolli to Its Board of Directors

Intuitive Surgical, Inc. Announces Executive Changes

Insufficient new directors

Recent updates

Third quarter 2024 earnings released: EPS: US$1.59 (vs US$1.18 in 3Q 2023)

Intuitive Appoints David J. Rosa as Board of Directors

Second quarter 2024 earnings released: EPS: US$1.48 (vs US$1.20 in 2Q 2023)

Now 29% overvalued after recent price rise

Intuitive Surgical, Inc. Announces FDA Clearance of Revised Da Vinci Xi and X Labeling on Radical Prostatectomy

Intuitive Elects Lewis Chew as Board of Directors

First quarter 2024 earnings released: EPS: US$1.54 (vs US$1.02 in 1Q 2023)

Intuitive Surgical, Inc., Annual General Meeting, Apr 25, 2024

Intuitive Surgical, Inc. Announces FDA Clearance of Fifth-Generation Robotic System, Da Vinci 5

Full year 2023 earnings released: EPS: US$5.12 (vs US$3.72 in FY 2022)

Intuitive Surgical, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year of 2023

Intuitive Surgical, Inc. Appoints Sreelakshmi Kolli to Its Board of Directors

Third quarter 2023 earnings released: EPS: US$1.18 (vs US$0.91 in 3Q 2022)

Second quarter 2023 earnings released: EPS: US$1.20 (vs US$0.86 in 2Q 2022)

Intuitive Surgical, Inc.(NasdaqGS:ISRG) dropped from Russell 1000 Value Index

Intuitive Surgical, Inc. Announces Executive Changes

Insufficient new directors

First quarter 2023 earnings released: EPS: US$1.02 (vs US$1.02 in 1Q 2022)

Full year 2022 earnings released: EPS: US$3.72 (vs US$4.79 in FY 2021)

Intuitive Surgical, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year 2022

Third quarter 2022 earnings released: EPS: US$0.91 (vs US$1.07 in 3Q 2021)

Investor sentiment improved over the past week

Now 22% undervalued after recent price drop

Second quarter 2022 earnings released: EPS: US$0.86 (vs US$1.45 in 2Q 2021)

First quarter 2022 earnings released: EPS: US$1.02 (vs US$1.20 in 1Q 2021)

First quarter 2022 earnings released: EPS: US$1.02 (vs US$1.20 in 1Q 2021)

Intuitive Surgical, Inc., Annual General Meeting, Apr 28, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Intuitive Receives FDA Clearance for 8 mm SureForm 30 Curved-Tip Stapler

Third quarter 2021 earnings released: EPS US$2.17 (vs US$0.89 in 3Q 2020)

Second quarter 2021 earnings released: EPS US$4.36 (vs US$0.58 in 2Q 2020)

First quarter 2021 earnings released: EPS US$3.61 (vs US$2.69 in 1Q 2020)

New 90-day high: €675

Full year 2020 earnings released: EPS US$9.07 (vs US$11.95 in FY 2019)

Revenue beats expectations

Revenue beats expectations

Full year 2020 earnings released: EPS US$9.07

Intuitive Surgical, Inc. to Report Q4, 2020 Results on Jan 21, 2021

New 90-day high: €671

New 90-day high: €667

Third-quarter earnings released: Revenue beats expectations

Third quarter earnings released

New 90-day high: €646

New 90-day high - €603

Analyse CEO-vergoeding

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd